IRIS
COMOLLI, GIUDITTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 405
EU - Europa 336
AS - Asia 135
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 401
IT - Italia 117
IE - Irlanda 109
CN - Cina 105
FI - Finlandia 37
DE - Germania 27
SG - Singapore 18
SE - Svezia 11
BE - Belgio 10
UA - Ucraina 8
GB - Regno Unito 7
IN - India 4
CA - Canada 3
JP - Giappone 3
CZ - Repubblica Ceca 2
FR - Francia 2
LK - Sri Lanka 2
NL - Olanda 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LT - Lituania 1
MA - Marocco 1
Totale 879
Salva come PNG Salva come JPEG
Città #
Dublin 105
Chandler 78
Ashburn 40
New York 38
Boardman 31
Helsinki 31
Pavia 27
Ann Arbor 26
Milan 26
Shanghai 25
Beijing 18
Nanjing 18
Princeton 17
Lawrence 14
Seattle 14
Jacksonville 13
Wilmington 13
Singapore 12
Medford 11
Rome 9
Brussels 8
Munich 8
Hebei 7
Los Angeles 7
Nanchang 7
Shenyang 7
Corsico 4
Falls Church 4
Piscataway 4
Pune 4
Washington 4
Cascina 3
Hangzhou 3
Tokyo 3
Toronto 3
Woodbridge 3
Bereguardo 2
Brescia 2
Changsha 2
Colombo 2
Jette 2
Jiaxing 2
Jinan 2
Kemerovo 2
San Francisco 2
Serrone 2
Tianjin 2
Turin 2
Verona 2
Amsterdam 1
Baoding 1
Boves 1
Brno 1
Cambridge 1
Chengdu 1
Como 1
Dallas 1
Fairfield 1
Ferrara di Monte Baldo 1
Guangzhou 1
Haifa 1
Hengyang 1
Jining 1
Lanzhou 1
Leawood 1
London 1
Motta Visconti 1
Norwalk 1
Olomouc 1
Quito 1
Rovello Porro 1
San Diego 1
Shenzhen 1
Tbilisi 1
Tirana 1
Totale 697
Salva come PNG Salva come JPEG
Nome #
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 88
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 61
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 60
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 58
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 56
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 53
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 47
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 44
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 43
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 42
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 36
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 35
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 35
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 28
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 23
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 19
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 18
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 18
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 18
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 17
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 15
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 14
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 12
Totale 908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 2 1 3 3 4 0 10 11 0
2020/202155 3 2 8 2 5 2 3 14 5 4 6 1
2021/202297 3 2 2 2 4 4 7 8 1 12 10 42
2022/2023298 18 27 4 18 12 20 0 7 127 2 58 5
2023/2024270 25 35 12 9 14 83 28 17 1 9 21 16
2024/202562 17 35 10 0 0 0 0 0 0 0 0 0
Totale 908